Cochlear Limited (($CHEOF)) announced an update on their ongoing clinical study. Study Overview: Cochlear Limited is conducting a post-market ...

In the United States, the Osia System is now cleared for children ages 5 and older The Osia System, which launched commercially in 2020, is indicated for people with conductive hearing loss, mixed ...

The U.S. FDA has cleared Cochlear Ltd.’s newest cochlear implant, the Osia 2 system, an active implantable bone conduction hearing system. Unlike Cochlear’s traditional implant, the Osia implant ...

The new Osia ® System with Osia OSI300 Implant enables patients to undergo MRI at 3.0 Tesla (T) without the need for surgery This has been made possible by the OSI300's unique Piezo Power™ technology ...

The Cochlear Limited (ASX:COH) share price is pushing higher on Monday after receiving FDA approval for the Osia 2 System. The Cochlear Limited (ASX: COH) share price is pushing higher on Monday ...

Freshman year of college brings new challenges and opportunities for every student. For Timothy Bilik, his freshman year was the first school year he was able to hear his teachers and classmates out ...

LONE TREE, Colo., April 19, 2024 /PRNewswire/ -- - Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, obtained U.S. Food and Drug Administration (FDA) clearance to lower ...

Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, introduces its next generation cochleartm osia® system with the ability to have an MRI at 3.0 T, designed to improve ...